Cargando…

Peripheral Complement Factor-Based Biomarkers for Patients with First-Episode Schizophrenia

OBJECTIVE: Schizophrenia (SCZ) is a severe, protracted neurological disorder that causes disruptive conduct in millions of individuals globally. Discovery of potential biomarkers in clinical settings would lead to the development of efficient diagnostic techniques and an awareness of the disease’s p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Yin, Xu, Yayun, Xia, Qingrong, Shan, Feng, Liang, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295471/ https://www.ncbi.nlm.nih.gov/pubmed/37384352 http://dx.doi.org/10.2147/NDT.S420475

Ejemplares similares

Peripheral blood cytokines as potential diagnostic biomarkers of suicidal ideation in patients with first-episode drug-naïve major depressive disorder
por: Xu, Yayun, et al.
Publicado: (2022)

Comparison of serum cytokines levels in normal-weight and overweight patients with first-episode drug-naïve major depressive disorder
por: Gao, Wenfan, et al.
Publicado: (2022)

Complement system biomarkers in first episode psychosis
por: Kopczynska, Maja, et al.
Publicado: (2019)

Peripheral Biomarkers for First-Episode Psychosis—Opportunities from the Neuroinflammatory Hypothesis of Schizophrenia
por: Trovão, Nuno, et al.
Publicado: (2019)

Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia
por: Gracias, Jessica, et al.
Publicado: (2022)

Serum CC Chemokines as Potential Biomarkers for the Diagnosis of Major Depressive Disorder
por: Gao, Wenfan, et al.
Publicado: (2022)

Association of elevated levels of peripheral complement components with cortical thinning and impaired logical memory in drug-naïve patients with first-episode schizophrenia
por: Yu, Hua, et al.
Publicado: (2023)

Network Association of Biochemical and Inflammatory Abnormalities With Psychiatric Symptoms in First-Episode Schizophrenia Patients
por: Yan, Junwei, et al.
Publicado: (2022)

Associated Factors of Quality of Life in First-Episode Schizophrenia Patients
por: Song, Yun Young, et al.
Publicado: (2011)

Follow-up of N400 in the Rehabilitation of First-episode Schizophrenia
por: Du, Xiang-Dong, et al.
Publicado: (2015)

Association between Peripheral Inflammatory Cytokines and Cognitive Function in Patients with First-Episode Schizophrenia
por: Baek, Seon-Hwa, et al.
Publicado: (2022)

Treatment Response in First-episode Schizophrenia
por: Schennach, Rebecca, et al.
Publicado: (2012)

The neurobiology and treatment of first-episode schizophrenia
por: Kahn, R S, et al.
Publicado: (2015)

Dysexecutive Behavior in First-Episode Schizophrenia
por: Orellana, Gricel, et al.
Publicado: (2022)

Decreased bilateral thalamic gray matter volume in first-episode schizophrenia with prominent hallucinatory symptoms: A volumetric MRI study
por: Huang, Peng, et al.
Publicado: (2015)

Gender Difference in the Prodromal Symptoms of First-episode Schizophrenia
por: Choi, Jung-Seok, et al.
Publicado: (2009)

The Differences between Gluten Sensitivity, Intestinal Biomarkers and Immune Biomarkers in Patients with First-Episode and Chronic Schizophrenia
por: Dzikowski, Michał, et al.
Publicado: (2020)

Disease-relevant autoantibodies in first episode schizophrenia
por: Zandi, Michael S., et al.
Publicado: (2010)

Executive attention impairment in first-episode schizophrenia
por: Orellana, Gricel, et al.
Publicado: (2012)

Sleep quality in first-episode schizophrenia patients
por: Abdellatif, M., et al.
Publicado: (2023)

Altered Expression of Glucocorticoid Receptor and Neuron-Specific Enolase mRNA in Peripheral Blood in First-Episode Schizophrenia and Chronic Schizophrenia
por: Liu, Yong, et al.
Publicado: (2020)

The contribution of the cingulate cortex: treating depressive symptoms in first-episode drug naïve schizophrenia
por: Shen, Haoran, et al.
Publicado: (2023)

Associations Between Genotype and Peripheral Complement Proteins in First-Episode Psychosis: Evidences From C3 and C4
por: Chen, Yu, et al.
Publicado: (2021)

Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications
por: Chen, Lei, et al.
Publicado: (2021)

Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients
por: Rodríguez, Natalia, et al.
Publicado: (2022)

Altered functional connectivity of cerebellar networks in first-episode schizophrenia
por: Feng, Sitong, et al.
Publicado: (2022)

Cognitive deficits and white matter abnormalities in never-treated first-episode schizophrenia
por: Yang, Mi, et al.
Publicado: (2020)

APOA-I: A Possible Novel Biomarker for Metabolic Side Effects in First Episode Schizophrenia
por: Song, Xueqin, et al.
Publicado: (2014)

Altered asymmetries of resting‐state MRI in the left thalamus of first‐episode schizophrenia
por: Liu, Sha, et al.
Publicado: (2022)

Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability
por: Hatzimanolis, Alex, et al.
Publicado: (2022)

Effects of Risperidone and Paliperidone on Brain-Derived Neurotrophic Factor and N400 in First-Episode Schizophrenia
por: Wu, Rong-Qin, et al.
Publicado: (2018)

Psychopathology and treatment responsiveness of patients with first-episode schizophrenia
por: Češková, Eva, et al.
Publicado: (2005)

Reduced Context Effects on Retrieval in First-Episode Schizophrenia
por: Talamini, Lucia M., et al.
Publicado: (2010)

Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia
por: Parellada, Eduard, et al.
Publicado: (2012)

Long-acting Injectable Antipsychotics in First-episode Schizophrenia
por: Jeong, Hyun-Ghang, et al.
Publicado: (2013)

Hippocampal Subfield Volumes in First Episode and Chronic Schizophrenia
por: Kawano, Mitsuhiko, et al.
Publicado: (2015)

Increased Blood-Reelin-Levels in First Episode Schizophrenia
por: Hornig, Tobias, et al.
Publicado: (2015)

Symptoms at Onset in First Episode Schizophrenia: Caregivers Perspectives
por: Tharoor, Hema, et al.
Publicado: (2015)

Dissecting the Heterogeneity of Treatment Response in First-Episode Schizophrenia
por: Malhotra, Anil K.
Publicado: (2015)

31. OPTIMISE-ING THE TREATMENT OF FIRST-EPISODE SCHIZOPHRENIA
por: Arango, Celso
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1e497g98d8td5v6eti8v8n111k